H.C. Wainwright research firm expressed continued confidence in shares of Harmony Biosciences Holdings Inc. (NASDAQ:HRMY), maintaining a Buy rating and a $75.00 price target for the company's stock.
The biggest stories of the day delivered to your inbox.
Check out this comprehensive USB Pan Tilt Zoom (PTZ) video solution.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback